About B2s Pharma Private Limited
Data last updated:
B2s Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2016PTC209111. Its GSTIN is 19AAGCB5922P1Z4 (West Bengal).
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors Sharmila Saha and Sudipta Das.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Wireless Gate Purba Rabindra Pally Surya Sen Street P.O. Nonachandanpukur, Kolkata, West Bengal, India – 700122.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.21 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net profit of ₹34,798 (net margin 0.3%) and EBITDA of ₹56,913 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 45% over three years and 33% over five years.
As per MCA filings, the company has open charges of ₹9.99 Lakh on record. Court records list 11 cases involving the company, including 11 filed against it; 7 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website b2spharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressWireless Gate Purba Rabindra Pally Surya Sen Street P.O. Nonachandanpukur, Kolkata, West Bengal, India – 700122
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of B2s Pharma Private Limited
The main business activity of B2s Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of B2s Pharma Private Limited
B2s Pharma Private Limited is audited by BERIWAL & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BERIWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of B2s Pharma Private Limited
B2s Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharmila Saha | Director | 13 Oct 2022 | 3 Years 11 Months | Current |
| Sudipta Das | Director | 05 Jan 2016 | 10 Years 9 Months | Current |
Financials of B2s Pharma Private Limited FY 2022 filings available
B2s Pharma Private Limited reported revenue of ₹1.21 Cr (up 54% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of B2s Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 54% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of B2s Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.21 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹56,913 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹34,798 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of B2s Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of B2s Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of B2s Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of B2s Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2018 | State Bank of India | ₹9.99 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at B2s Pharma Private Limited
Employment history and EPFO contributions of people linked to B2s Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of B2s Pharma Private Limited
B2s Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAGCB5922P1Z4 | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of B2s Pharma Private Limited
B2s Pharma Private Limited has 11 court cases on record: 11 filed against it. 7 cases are pending and 4 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 11 | 7 |
Cases on record (5 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Nagpur, Maharashtra | Civil suit | Filed against the company by Ikon Remedies Private Limited | Pending |
| District court, South Twenty Four Parganas, West Bengal | Criminal complaint | Filed against the company by Trireme Life Sciences Private Limited | Pending |
| District court, New Delhi, Delhi | Execution petition | Filed against the company by Dr. Morepen Limited | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Aditya Birla Finance Limited | Disposed |
| District court, New Delhi, Delhi | Civil suit | Filed against the company by Dr. Morepen Limited | Disposed |
Full case history
All 11 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for B2s Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by B2s Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of B2s Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of B2s Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on B2s Pharma Private Limited
Frequently Asked Questions about B2s Pharma Private Limited
B2s Pharma is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 January 2016 (10+ years old) and is registered under CIN U74900WB2016PTC209111.
B2s Pharma reported revenue of ₹1.21 Cr for FY 2022 (up 54% YoY).
B2s Pharma has 2 current directors:
- Sharmila Saha - Director
- Sudipta Das - Director
B2s Pharma reported a net profit of ₹34,798 (net margin 0.3%) and EBITDA of ₹56,913 (EBITDA margin 0.5%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of B2s Pharma is 45% over three years and 33% over five years. In the latest year (FY 2022) revenue rose 54%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of B2s Pharma is 19AAGCB5922P1Z4, registered in West Bengal.
The CIN (Corporate Identification Number) of B2s Pharma is U74900WB2016PTC209111. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
B2s Pharma has 11 court cases on record: 11 filed against it. 7 are pending.
B2s Pharma was incorporated on 05 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kolkata.